These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 30107996)
1. Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection. Lee SH; Kang HJ; Lee DH; Kang SM; Quan FS Vaccine; 2018 Sep; 36(38):5692-5700. PubMed ID: 30107996 [TBL] [Abstract][Full Text] [Related]
2. Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection. Kang HJ; Lee SH; Chu KB; Lee DH; Quan FS Korean J Parasitol; 2018 Oct; 56(5):429-435. PubMed ID: 30419728 [TBL] [Abstract][Full Text] [Related]
3. Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Lee SH; Kang HJ; Lee DH; Quan FS Front Immunol; 2018; 9():3073. PubMed ID: 30666253 [TBL] [Abstract][Full Text] [Related]
4. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection. Lee SH; Kim AR; Lee DH; Rubino I; Choi HJ; Quan FS PLoS One; 2017; 12(4):e0175644. PubMed ID: 28406951 [TBL] [Abstract][Full Text] [Related]
5. Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses. Lee SH; Chu KB; Kang HJ; Quan FS PLoS One; 2019; 14(8):e0220865. PubMed ID: 31465461 [TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii virus-like particle vaccination alleviates inflammatory response in the brain upon T gondii infection. Kang HJ; Chu KB; Lee SH; Kim MJ; Park H; Jin H; Moon EK; Quan FS Parasite Immunol; 2020 Jun; 42(6):e12716. PubMed ID: 32249951 [TBL] [Abstract][Full Text] [Related]
7. Protective immunity induced by CpG ODN-adjuvanted virus-like particles containing Toxoplasma gondii proteins. Kang HJ; Chu KB; Kim MJ; Lee SH; Park H; Jin H; Moon EK; Quan FS Parasite Immunol; 2021 Jan; 43(1):e12799. PubMed ID: 33058167 [TBL] [Abstract][Full Text] [Related]
8. Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice. Zhu YC; He Y; Liu JF; Chen J Parasite; 2020; 27():26. PubMed ID: 32315596 [TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Liu MM; Yuan ZG; Peng GH; Zhou DH; He XH; Yan C; Yin CC; He Y; Lin RQ; Song HQ; Zhu XQ Parasitol Res; 2010 Apr; 106(5):1079-84. PubMed ID: 20177910 [TBL] [Abstract][Full Text] [Related]
10. Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice. Kang HJ; Chu KB; Lee SH; Kim MJ; Park H; Jin H; Quan FS Korean J Parasitol; 2019 Oct; 57(5):543-547. PubMed ID: 31715698 [TBL] [Abstract][Full Text] [Related]
11. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Yuan ZG; Zhang XX; Lin RQ; Petersen E; He S; Yu M; He XH; Zhou DH; He Y; Li HX; Liao M; Zhu XQ Vaccine; 2011 Sep; 29(38):6614-9. PubMed ID: 21762755 [TBL] [Abstract][Full Text] [Related]
12. Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii. Lee DH; Lee SH; Kim AR; Quan FS PLoS One; 2016; 11(8):e0161231. PubMed ID: 27548677 [TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368 [TBL] [Abstract][Full Text] [Related]
14. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice. Zheng B; Lu S; Tong Q; Kong Q; Lou D Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460 [TBL] [Abstract][Full Text] [Related]
15. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice. Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035 [TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice. Li XZ; Wang XH; Xia LJ; Weng YB; Hernandez JA; Tu LQ; Li LT; Li SJ; Yuan ZG BMC Infect Dis; 2015 Mar; 15():114. PubMed ID: 25886737 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route. Rashid I; Moiré N; Héraut B; Dimier-Poisson I; Mévélec MN Med Microbiol Immunol; 2017 Feb; 206(1):53-62. PubMed ID: 27757545 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
19. Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein. Eom GD; Chu KB; Kang HJ; Kim MJ; Yoon KW; Mao J; Lee SH; Ahmed MA; Moon EK; Quan FS PLoS One; 2023; 18(4):e0283928. PubMed ID: 37104285 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii. Wang L; Lu G; Zhou A; Han Y; Guo J; Zhou H; Cong H; He S Parasite Immunol; 2016 Apr; 38(4):209-17. PubMed ID: 26802673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]